Group One Trading
CAI

Group One Trading’s Caris Life Sciences CAI Stock Holding History

Group One Trading’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241K Buy
13,500
+5,000
+59% +$109K ﹤0.01% 3963
2025
Q4 		$229K Sell
8,500
-8,300
-49% -$234K ﹤0.01% 4259
2025
Q3 		$508K Buy
+16,800
New +$536K ﹤0.01% 3689

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's CAI Position: Q1 2026 in Review

Group One Trading reduced its Caris Life Sciences (CAI) stake by 31% in Q1 2026, selling an estimated $179K and leaving 18,173 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #3728.

Group One Trading first reported a position in CAI in Q4 2025 and has held it in 2 quarters since. The position peaked at $711K in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Group One Trading held 18,173 shares of Caris Life Sciences worth $325K as of Q1 2026.
  • Group One Trading sold 8,170 Caris Life Sciences shares in Q1 2026, an estimated $179K.
  • Caris Life Sciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3728 holding.
  • Group One Trading first reported a position in Caris Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • Group One Trading's Caris Life Sciences position peaked at $711K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.